Skip to main content

Table 1 Clinical characteristics of NCPH patients

From: CT-based nomogram predicts esophageal gastric variceal bleeding in noncirrhotic portal hypertension caused by hepatic schistosomiasis

 

Training cohort

Testing cohort

 

Non-EGVB

(N = 144)

EGVB

(N = 77)

P

Non-EGVB

(N = 52)

EGVB

(N = 42)

P

Gender

     

0.905

 Female

66 (45.8%)

30 (39.0%)

0.401

23 (44.2%)

20 (47.6%)

 

 Male

78 (54.2%)

47 (61.0%)

 

29 (55.8%)

22 (52.4%)

 

Age

74.3 (7.9)

75.4 (9.4)

0.369

74.3 (7.0)

76.6 (7.7)

0.148

ALT (U/L)

22.0 (21.1)

27.9 (32.1)

0.153

19.0 (7.9)

22.4 (13.9)

0.166

AST (U/L)

26.7 (16.0)

31.2 (21.6)

0.105

25.6 (9.4)

28.9 (13.9)

0.194

Platelet

192 (67.0)

155 (53.0)

< 0.001

197 (63.2)

158 (55.2)

0.002

Triglyceride (mmol/L)

1.3 (1.0)

1.3 (1.09)

0.846

1.4 (1.1)

1.3 (1.5)

0.731

Cholesterol (mmol/L)

3.7 (0.9)

3.6 (0.9)

0.434

3.7 (1.2)

3.7 (1.3)

0.888

HDL (mmol/L)

1.0 (0.3)

1.1 (0.4)

0.536

1.0 (0.3)

0.9 (0.3)

0.167

LDL (mmol/L)

2.3 (0.6)

2.2 (0.5)

0.131

2.6 (1.0)

2.3 (0.8)

0.178

CRP (mg/L)

9.9 (16.0)

11.6 (14.7)

0.445

9.9 (13.6)

11.2 (11.3)

0.647

TB (µmol/L)

4.6 (4.3)

5.7 (4.5)

0.075

4.7 (4.5)

5.6 (4.5)

0.354

PT (s)

11.3 (1.4)

13.1 (2.3)

< 0.001

11.0 (1.1)

12.9 (1.8)

< 0.001

Albumin (g/L)

35.2 (4.7)

33.1 (6.2)

0.009

37.2 (4.8)

32.1 (5.0)

< 0.001

Creatinine (µmol/L)

71.3 (28.1)

80.2 (33.7)

0.048

69.1 (31.3)

88.0 (36.7)

0.01

INR

1.0 (0.1)

1.14 (0.2)

< 0.001

0.9 (0.1)

1.1 (0.1)

< 0.001

Varices score algorithms 1

0.27 (0.23)

0.57 (0.20)

< 0.001

0.24 (0.21)

0.55 (0.20)

< 0.001

Varices score algorithms 2

0.8 (1.1)

2.1 (0.8)

< 0.001

0.8 (0.9)

2.0 (0.9)

< 0.001

MELD score

51.0 (4.2)

54.3 (5.2)

< 0.001

50.4 (4.2)

55.0 (5.1)

< 0.001

Beta blocker

  

< 0.001

  

< 0.001

 Negative

118 (81.9%)

43 (55.8%)

 

48 (92.3%)

24 (57.1%)

 

 Positive

26 (18.1%)

34 (44.2%)

 

4 (7.7%)

18 (42.9%)

 
  1. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; EGVB, esophageal gastric variceal bleeding; HDL, high-density lipoprotein; INR, international normalized ratio; LDL, low-density lipoprotein; MELD, model for end-stage liver disease; PT, prothrombin time; TB, total bilirubin